BR1100662A - Compostos farmacologicamente aceitáveis; uso de um composto; e processo para a preparação dos compostos - Google Patents

Compostos farmacologicamente aceitáveis; uso de um composto; e processo para a preparação dos compostos

Info

Publication number
BR1100662A
BR1100662A BR1100662-5A BR1100662A BR1100662A BR 1100662 A BR1100662 A BR 1100662A BR 1100662 A BR1100662 A BR 1100662A BR 1100662 A BR1100662 A BR 1100662A
Authority
BR
Brazil
Prior art keywords
compounds
compound
preparation
pharmacologically acceptable
same
Prior art date
Application number
BR1100662-5A
Other languages
English (en)
Inventor
Raymond Bonnett
Morris Cyril Berenbaum
Original Assignee
Raymond Bonnett
Morris Cyril Berenbaum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raymond Bonnett, Morris Cyril Berenbaum filed Critical Raymond Bonnett
Publication of BR1100662A publication Critical patent/BR1100662A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BR1100662-5A 1988-03-11 1997-05-07 Compostos farmacologicamente aceitáveis; uso de um composto; e processo para a preparação dos compostos BR1100662A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805849A GB8805849D0 (en) 1988-03-11 1988-03-11 Porphyrins & cancer treatment

Publications (1)

Publication Number Publication Date
BR1100662A true BR1100662A (pt) 1999-10-13

Family

ID=10633278

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100662-5A BR1100662A (pt) 1988-03-11 1997-05-07 Compostos farmacologicamente aceitáveis; uso de um composto; e processo para a preparação dos compostos

Country Status (17)

Country Link
US (1) US4992257A (pt)
EP (1) EP0337601B1 (pt)
JP (1) JP2785033B2 (pt)
KR (1) KR970011392B1 (pt)
AT (1) ATE89002T1 (pt)
AU (1) AU611774C (pt)
BR (1) BR1100662A (pt)
CA (1) CA1338737C (pt)
DE (2) DE10299012I2 (pt)
ES (1) ES2055038T3 (pt)
GB (1) GB8805849D0 (pt)
HK (1) HK129693A (pt)
IE (1) IE63290B1 (pt)
LU (1) LU90907I2 (pt)
NL (1) NL300089I2 (pt)
NZ (1) NZ228225A (pt)
ZA (1) ZA891653B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162519A (en) * 1988-03-11 1992-11-10 Efamol Holdings Plc Porphyrins and cancer treatment
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US6362175B1 (en) * 1991-09-20 2002-03-26 The Trustees Of The University Of Pennsylvania Porphyrin compounds for imaging tissue oxygen
DE947222T1 (de) * 1992-11-20 2000-05-04 Univ British Columbia Vancouve Verfahren zur Aktivierung von photoempfindlichen Mitteln
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
JPH07233065A (ja) * 1993-12-27 1995-09-05 Canon Inc ピリリウム塩又はピリリウム類似塩を含む光化学治療薬
GB9408746D0 (en) * 1994-05-03 1994-06-22 Scotia Holdings Plc Tumour locallising photosensitising compounds
AU3758695A (en) * 1994-09-20 1996-04-09 Duke University Oxidoreductase activity of manganic porphyrins
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
ES2249784T3 (es) * 1995-06-07 2006-04-01 Duke University Antioxidantges de oxidantes.
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
EP0837141B1 (en) 1996-10-03 2003-01-08 Canon Kabushiki Kaisha Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis
US6582392B1 (en) * 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
CA2309154C (en) 1997-11-03 2010-02-16 Duke University Substituted porphyrins
DE19814405C2 (de) * 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
US6479477B1 (en) 1998-04-24 2002-11-12 Duke University Substituted porphyrins
ES2237146T3 (es) * 1998-08-28 2005-07-16 Destiny Pharma Limited Derivados de porfirina, su uso en terapia fotodinamica y dispositivos medicos que los contienen.
EP1155019B1 (en) 1999-01-25 2005-12-07 National Jewish Medical and Research Center Substituted porphyrins and their therapeutic use
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
GB0001455D0 (en) * 2000-01-21 2000-03-15 Scotia Holdings Plc Porphyrins and related compounds
US20030050297A1 (en) 2001-01-19 2003-03-13 Crapo James D. Cancer therapy
JP2005508864A (ja) 2001-06-01 2005-04-07 ナショナル・ジュウィッシュ・メディカル・アンド・リサーチ・センター 糖尿病の治療、または移植術における使用、または免疫寛容の誘導のためのオキシダントスカベンジャー
ATE520362T1 (de) 2001-12-03 2011-09-15 Ekos Corp Katheter mit mehreren ultraschall-abstrahlenden teilen
PT102721B (pt) * 2002-02-01 2011-01-24 Cipan Companhia Industr Prod De Antibioticos S A Compostos macrocíclicos tetrapirrólicos com rendimento quântico de oxigénio singuleto adequado à terapia fotodinâmica e processos para a sua preparação
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US7485721B2 (en) 2002-06-07 2009-02-03 Duke University Substituted porphyrins
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
MX2007000338A (es) 2004-06-09 2007-03-28 Quadra Logic Tech Inc Terapia fotodinamica para el tratamiento de trastornos hiperactivos de glandulas sebaceas.
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
DE102005015286A1 (de) * 2005-04-04 2006-10-05 Tetrapdt Gmbh Photosensibilisatoren als Arzneimittelträger für lokale Markierung und Therapie von neoplastischem Gewebe
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
WO2009002881A1 (en) 2007-06-22 2008-12-31 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
EP2231024A4 (en) * 2007-12-14 2015-03-18 Ekos Corp ULTRASOUND PULSE SHAPING
CA2725012C (en) 2008-05-23 2019-05-07 National Jewish Health Methods for treating injury associated with exposure to an alkylating species
WO2010033678A2 (en) 2008-09-18 2010-03-25 Ceramoptec Industries, Inc. Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt
US9211283B2 (en) 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
MX2013008175A (es) 2011-01-13 2013-12-16 Quadra Logic Tech Inc Composiciones farmacéuticas para suministro tópico de fotosensibilizadores y usos de los mismos.
JP2015522079A (ja) 2012-07-11 2015-08-03 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． 光線感作物質の局所送達のための医薬組成物及びその使用
US9550072B2 (en) 2012-08-03 2017-01-24 Cerca Solutions, LLC Diagnostic device, therapeutic device, and uses thereof
WO2016051361A1 (en) 2014-09-30 2016-04-07 Biolitec Unternehmensbeteiligungs Ii Ag Specifically meso-substituted porphyrins and chlorins for photodynamic therapy
EP3307388B1 (en) 2015-06-10 2022-06-22 Ekos Corporation Ultrasound catheter
US20220025185A1 (en) 2018-12-10 2022-01-27 Universitat Hamburg Specifically glyco-substituted porphyrins and chlorins for photodynamic therapy
EP4225759A1 (en) 2020-10-05 2023-08-16 biolitec Unternehmensbeteiligungs II AG Tetrapyrrole-based compounds and their formulations for anti-microbial therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2740794A (en) * 1954-07-26 1956-04-03 Exxon Research Engineering Co Synthesis of novel vanadium porphyrin
US3076813A (en) * 1957-11-13 1963-02-05 Monsanto Chemicals alpha, beta, gamma, sigma-tetra-arylporphins
US3687863A (en) * 1970-05-25 1972-08-29 Gen Telephone & Elect Optical filters containing tetraphenyl-porphins and method of making same
DE2308252A1 (de) * 1973-02-20 1974-08-22 Basf Ag Verfahren zur herstellung von mesotetraarylporphinen
US4330637A (en) * 1981-01-05 1982-05-18 Western Electric Company, Inc. Encapsulated electronic devices and encapsulating compositions
DE3464252D1 (en) * 1983-06-03 1987-07-23 Hoffmann La Roche Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments

Also Published As

Publication number Publication date
JP2785033B2 (ja) 1998-08-13
ES2055038T3 (es) 1994-08-16
NL300089I1 (nl) 2002-07-01
DE10299012I2 (de) 2004-05-06
NZ228225A (en) 1990-08-28
US4992257A (en) 1991-02-12
EP0337601A1 (en) 1989-10-18
AU611774C (en) 2002-02-21
CA1338737C (en) 1996-11-26
LU90907I2 (fr) 2003-04-30
GB8805849D0 (en) 1988-04-13
EP0337601B1 (en) 1993-05-05
AU611774B2 (en) 1991-06-20
DE10299012I1 (de) 2002-07-18
KR890014548A (ko) 1989-10-24
IE890687L (en) 1989-09-11
AU3097589A (en) 1989-09-14
JPH01275528A (ja) 1989-11-06
IE63290B1 (en) 1995-04-05
DE68906301D1 (de) 1993-06-09
HK129693A (en) 1993-12-03
NL300089I2 (nl) 2002-08-01
ATE89002T1 (de) 1993-05-15
KR970011392B1 (ko) 1997-07-10
ZA891653B (en) 1989-11-29
DE68906301T2 (de) 1993-09-30

Similar Documents

Publication Publication Date Title
BR1100662A (pt) Compostos farmacologicamente aceitáveis; uso de um composto; e processo para a preparação dos compostos
ATE42037T1 (de) Porphyrine und krebsbehandlung.
NL300241I1 (nl) Hydroxymethyl(methyleencyclopentyl)uurines en -pyrimidines.
ATE183182T1 (de) S-triazinderivate als lichtschutzmittel
ES2083569T3 (es) Nuevos derivados de ariletenileno y procedimiento para su preparacion.
ES2069137T3 (es) Derivados de imidazopiridina y su uso.
ITMI920528A1 (it) 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
MX9102582A (es) Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DE69002996D1 (de) Triphenylmethan-Derivate.
DK0692484T3 (da) Benzothiadiazinderivat, fremgangsmåde til fremstilling deraf samt farmaceutiske sammensætninger indeholdende derivatet
NO176911C (no) Diiodforbindelser for anvendelse ved fremstilling av morfolinylderivater av doxorubicin, og deres fremstilling
PT99756A (pt) Processo para a preparacao de 2-aril-5-(trifluorometil)pirroles uteis como agentes pesticidas e como intermediarios para a preparacao dos referidos agentes
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
DK0431579T3 (da) Substituerede cyclohexener som midler med virkning på centralnervesystemet
PT90302A (pt) Processo para a preparacao de derivados de lactamas hetero-tetraciclicas
ES2129401T3 (es) Uso de un compuesto terapeutico para el tratamiento de bronquitis.
PT98186A (pt) Processo para a preparacao de purinil- e de pirimidinil-tetra-hidrofuranos e de composicoes farmaceuticas que os contem
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
PT1264836E (pt) Processos para a preparacao de derivados de indolopirrolocarbazole
AU6029090A (en) Improvements in or relating to organic compounds
ES2057741T3 (es) Uso de un derivado de benzo(b)tiofeno-2-carboximidamida.

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96
B25A Requested transfer of rights approved

Free format text: BIOSCIENCE TECHNOLOGY INVESTMENT HOLDINGS LTD. (MY)